DK0557451T3 - Karakterisering af blodpladesygdomme - Google Patents
Karakterisering af blodpladesygdommeInfo
- Publication number
- DK0557451T3 DK0557451T3 DK92901259T DK92901259T DK0557451T3 DK 0557451 T3 DK0557451 T3 DK 0557451T3 DK 92901259 T DK92901259 T DK 92901259T DK 92901259 T DK92901259 T DK 92901259T DK 0557451 T3 DK0557451 T3 DK 0557451T3
- Authority
- DK
- Denmark
- Prior art keywords
- defects
- characterization
- activation
- ligand binding
- characterizing
- Prior art date
Links
- 208000013544 Platelet disease Diseases 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 230000007547 defect Effects 0.000 abstract 6
- 230000004913 activation Effects 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 208000013607 Glanzmann thrombasthenia Diseases 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000000684 flow cytometry Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010028537 myelofibrosis Diseases 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sampling And Sample Adjustment (AREA)
- Laminated Bodies (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/614,723 US5196309A (en) | 1990-11-15 | 1990-11-15 | Characterization of platelet aggregation disorders |
PCT/US1991/008579 WO1992008982A1 (en) | 1990-11-15 | 1991-11-15 | Characterization of platelet aggregation disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0557451T3 true DK0557451T3 (da) | 1998-09-23 |
Family
ID=24462455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92901259T DK0557451T3 (da) | 1990-11-15 | 1991-11-15 | Karakterisering af blodpladesygdomme |
Country Status (13)
Country | Link |
---|---|
US (2) | US5196309A (el) |
EP (1) | EP0557451B1 (el) |
JP (1) | JP3186765B2 (el) |
AT (1) | ATE163481T1 (el) |
AU (1) | AU650312B2 (el) |
CA (1) | CA2096230C (el) |
DE (1) | DE69128966T2 (el) |
DK (1) | DK0557451T3 (el) |
ES (1) | ES2112310T3 (el) |
GR (1) | GR3026510T3 (el) |
IE (1) | IE62627B1 (el) |
PT (1) | PT99532B (el) |
WO (1) | WO1992008982A1 (el) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5427913A (en) * | 1992-12-03 | 1995-06-27 | Alberta Cancer Board | Methods for determining platelet function |
US5763199A (en) * | 1994-09-29 | 1998-06-09 | Mount Sinai School Of Medicine Of The City University Of New York | Platelet blockade assay |
US5561047A (en) * | 1994-12-13 | 1996-10-01 | The Trustees Of The University Of Pennsylvania | Method of identifying effectors of integrin activation |
US6521211B1 (en) * | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
GB9519667D0 (en) * | 1995-09-27 | 1995-11-29 | Univ Manchester | Pharmaceutical composition |
EP0983509B1 (en) * | 1997-05-14 | 2005-08-17 | Biosite Diagnostics Inc. | Rapid evaluation of the ratio of biological molecules |
WO1998053320A1 (en) * | 1997-05-20 | 1998-11-26 | The Johns Hopkins University | A novel thrombopoietin signaling defect in polycythemia vera platelets |
FR2764388B1 (fr) * | 1997-06-06 | 1999-08-27 | Biocytex | Nouvelle methode d'analyse des recepteurs plaquettaires gpiib/iiia |
US6210904B1 (en) | 1997-10-14 | 2001-04-03 | Merck & Co., Inc. | Anticoagulant test |
US6040182A (en) * | 1997-11-12 | 2000-03-21 | Becton Dickinson And Company | Method and materials for efficiency protein immobilization on tissue culture treated assay plates |
US6063584A (en) * | 1997-11-21 | 2000-05-16 | Merck & Co., Inc. | Anticoagulant test |
US20030003515A1 (en) * | 2000-12-05 | 2003-01-02 | Farrell David H. | Monocloral antibody-based diagnostic assay for gamma fibrinogen |
US20040131500A1 (en) * | 2002-01-18 | 2004-07-08 | Chow Herbert S. | Device and method for evaluating platelets |
WO2005007868A2 (en) | 2003-07-08 | 2005-01-27 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
US20070243632A1 (en) | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
JP2010261790A (ja) * | 2009-05-01 | 2010-11-18 | Takemichi Kanazawa | 血管障害の素因の検査方法、及び治療法の選択方法 |
WO2015138916A1 (en) * | 2014-03-14 | 2015-09-17 | Yves Claude Nicolau | Myo-inositol trispyrophoshate as an anti-diabetic agent |
PT3259402T (pt) * | 2015-01-14 | 2020-04-06 | Sorin Dinu | Dispositivo robusto para nivelar a areia em dimensões prescritas e para colocar dutos em um canal de esgoto |
WO2019047042A1 (zh) * | 2017-09-05 | 2019-03-14 | 深圳迈瑞生物医疗电子股份有限公司 | 血小板聚集样本的报警方法、血细胞分析仪及存储介质 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783330A (en) * | 1984-11-15 | 1988-11-08 | New England Medical Center Hospitals, Inc. | Monoclonal antibodies to activated platelets |
US4820505A (en) * | 1985-04-04 | 1989-04-11 | Scripps Clinic And Research Foundation | Detection of activated platelets with antibodies to thrombospondin |
US5114842A (en) * | 1987-07-08 | 1992-05-19 | The Scripps Research Institute | Peptides and antibodies that inhibit platelet adhesion |
-
1990
- 1990-11-15 US US07/614,723 patent/US5196309A/en not_active Expired - Lifetime
-
1991
- 1991-11-14 IE IE397591A patent/IE62627B1/en not_active IP Right Cessation
- 1991-11-15 ES ES92901259T patent/ES2112310T3/es not_active Expired - Lifetime
- 1991-11-15 DE DE69128966T patent/DE69128966T2/de not_active Expired - Fee Related
- 1991-11-15 CA CA002096230A patent/CA2096230C/en not_active Expired - Fee Related
- 1991-11-15 PT PT99532A patent/PT99532B/pt not_active IP Right Cessation
- 1991-11-15 AU AU90824/91A patent/AU650312B2/en not_active Ceased
- 1991-11-15 AT AT92901259T patent/ATE163481T1/de not_active IP Right Cessation
- 1991-11-15 EP EP92901259A patent/EP0557451B1/en not_active Expired - Lifetime
- 1991-11-15 JP JP50230492A patent/JP3186765B2/ja not_active Expired - Fee Related
- 1991-11-15 WO PCT/US1991/008579 patent/WO1992008982A1/en active IP Right Grant
- 1991-11-15 DK DK92901259T patent/DK0557451T3/da active
-
1994
- 1994-06-23 US US08/264,759 patent/US5656442A/en not_active Expired - Lifetime
-
1998
- 1998-04-03 GR GR980400694T patent/GR3026510T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5196309A (en) | 1993-03-23 |
PT99532A (pt) | 1992-09-30 |
DE69128966D1 (de) | 1998-04-02 |
JP3186765B2 (ja) | 2001-07-11 |
GR3026510T3 (en) | 1998-07-31 |
PT99532B (pt) | 1999-04-30 |
ES2112310T3 (es) | 1998-04-01 |
CA2096230C (en) | 2003-05-27 |
US5656442A (en) | 1997-08-12 |
WO1992008982A1 (en) | 1992-05-29 |
AU650312B2 (en) | 1994-06-16 |
IE913975A1 (en) | 1992-05-20 |
ATE163481T1 (de) | 1998-03-15 |
CA2096230A1 (en) | 1992-05-16 |
DE69128966T2 (de) | 1998-06-18 |
EP0557451A1 (en) | 1993-09-01 |
AU9082491A (en) | 1992-06-11 |
IE62627B1 (en) | 1995-02-22 |
EP0557451A4 (en) | 1994-06-01 |
EP0557451B1 (en) | 1998-02-25 |
JPH06504842A (ja) | 1994-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0557451T3 (da) | Karakterisering af blodpladesygdomme | |
Papadimitriou et al. | The complexity of immunohistochemical staining pattern of hodgkin and sternberg‐reed cells—demonstration of immunoglobulin, albumin, α1‐antichymotrypsin and lysozyme | |
ATE128183T1 (de) | Peptide und antikörper, die die bindung von blutplättchen verhindern. | |
DE69129896D1 (de) | Gegen cd3 gerichtete antikörper | |
ATE153701T1 (de) | Immunchromatographischer assay und verfahren zur nutzung desselben | |
ATE504601T1 (de) | Anti-cd3-antikörper zur verwendung zur induzierung von immunsuppression | |
ATE76301T1 (de) | Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene. | |
DE69534996D1 (de) | Monoklonaler antikörper gegen flt4-rezeptor-tyrosinkinase und dessen verwendung zur diagnose und therapie | |
ATE429449T1 (de) | Anti-fas-ligand antikörper und testmethode unter verwendung derselben | |
ES2070488T5 (es) | Procedimiento para la diagnosis de enfermedades tumorales. | |
DE69032112D1 (de) | Verfahren zur Isolierung von fetalen Zytotrophoblastzellen | |
ATE121788T1 (de) | Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse. | |
Shinjo et al. | Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly‐devised quantitative flow‐cytometric assay | |
ES8501630A1 (es) | Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo. | |
ATE151882T1 (de) | Karzinomverwandtes haptoglobin (hpr) | |
CA2308604A1 (en) | Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use | |
IL123247A0 (en) | Assay for the diagnosis of dementia | |
DE69229284D1 (de) | Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden | |
DE3785175D1 (de) | A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung. | |
Loyson et al. | Immunohistochemical analysis of decalcified paraffin‐embedded human bone marrow biopsies with emphasis on MHC class I and CD34 expression | |
DE69111429D1 (de) | Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen. | |
Michalska et al. | Flow cytometry crossmatch in living donor renal transplantation | |
TH131300B (th) | ตัวแปรอิมมูโนกลูบูลินและการใช้สิ่งนั้น |